Biotechnology

Future Prospects Of The Middle East And Asia Pacific Cell And Gene Therapy Market

Ashish Thapa

Future Prospects Of The Middle East And Asia Pacific Cell And Gene Therapy Market

Market Overview:

Cell and gene therapies involve treatment methods that repair or replace defective genes or introduce new genes and cells into a patient's body to cure disease. These therapies provide long-lasting benefits for various incurable and life-threatening diseases.

Market Key Trends:

One of the major trends in the Middle East and Asia Pacific cell and gene therapy market is the increase in research and development activities. There has been significant development in the area of cell and gene therapy over the past few years. Various biotechnology companies and academic research institutes are conducting extensive research to develop innovative cell and gene therapy products for treating cancer, neurological disorders, cardiovascular diseases and other conditions. This has increased the translational capabilities, thereby driving the market growth.

Segment Analysis

The Middle East and Asia Pacific cell and gene therapy market is segmented into application and technology. The application segment is further divided into oncology, cardiovascular diseases, neurological disorders, orthopedic disorders, and others. Among these, the oncology segment dominated in 2021 due to increased prevalence of cancer and growing focus on development of cell-based therapies for cancer treatment.

The Middle East and Asia Pacific Cell and Gene Therapy Market Demand is estimated to be valued at US$ 2,616.8 Million in 2023 and is expected to exhibit a CAGR of 17.3% over the forecast period 2021-2028, as highlighted in a new report published by Coherent Market Insights.

Key Takeaways

The Middle East and Asia Pacific cell and gene therapy market is expected to witness high growth, exhibiting CAGR of 17.3% over the forecast period, due to increasing prevalence of chronic diseases and growing focus on development of advanced therapies.

Regional analysis

Among regions, Asia Pacific is expected to grow at the fastest rate due to rising healthcare expenditure, increasing collaborations between academic and research institutes, and supporting government initiatives for development of regenerative medicines. China dominates the Asia Pacific market due to presence of major market players and growing clinical research activities in the country.

Key players

Key players operating in the Middle East and Asia Pacific cell and gene therapy market are Novartis International AG, Pfizer, Inc., Sanofi S.A., Amgen, Inc., Regeneron Pharmaceuticals, Inc., F. Hoffmann-La Roche AG, Bluebird Bio, Inc. (Celgene Corporation), Gene biotherapeutics, Sibiono GeneTech Co. Ltd., Kolon TissueGene, Inc., Horama S.A., MeiraGTx Limited, Gilead Sciences, Inc., Biogen INC., Organogenesis, Inc., JCR Pharmaceuticals Co. Ltd, uniQure N.V., WuxiAppTec, Lonza, and Immuneel Therapeutics Pvt Ltd.

Ashish Thapa

The Global Middle East And Asia Pacific Cell And Gene Therapy Market Growth Accelerated By Increasing Investments

Pooja Khodke 2023-12-28

The Middle East and Asia Pacific cell and gene therapy market consist of advanced therapies including gene editing, gene therapy, immunotherapy, and cellular therapy that can potentially cure chronic diseases including cancers, genetic disorders, and infectious diseases. The global Middle East And Asia Pacific Cell And Gene Therapy Market is estimated to be valued at Us$ 3600. The facility will offer end-to-end cell therapy CDMO services including cell culture development, GMP cell banking, manufacturing, fill and finish, analytical testing, and distribution of cell therapy products. The global Middle East and Asia Pacific Cell and Gene Therapy Market is estimated to be valued at US$ 3600. Key players related content comprises: Key players operating in the Middle East and Asia Pacific cell and gene therapy market are Codexis Inc.

The Middle East And Asia Pacific Cell And Gene Therapy Market Set To Reach New Heights Driven By Increasing Prevalence Of Chronic Diseases

Leena Shedmake 2024-02-13

The cell and gene therapy market in the Middle East and Asia Pacific region has been growing at a significant pace over the past few years. The Middle East and Asia Pacific cell and gene therapy market is estimated to be valued at US$ 4147. Impact of COVID-19 on the Middle East and Asia Pacific Cell and Gene Therapy Market:The COVID-19 pandemic has significantly impacted the Middle East and Asia Pacific cell and gene therapy market. Geographical concentration of the Middle East and Asia Pacific Cell and Gene Therapy Market:The Global Middle East And Asia Pacific Cell And Gene Therapy Market Growth is currently concentrated in countries like China, Japan, South Korea and Australia in terms of value. Fastest growing region for the Middle East and Asia Pacific Cell and Gene Therapy Market:The Middle East is poised to be the fastest growing region for the cell and gene therapy market during the forecast period.

Rising Potential of Middle East and Asia Pacific Cell and Gene Therapy

Poonam 2024-02-20

Emerging Markets Show Strong Development With a rapidly growing population and increasing healthcare spending, the Middle East and Asia Pacific provide attractive markets for cell and gene therapy companies. In the Middle East, Saudi Arabia is emerging as a leader with the launch of the National Gene Therapy Program in 2018. The United Arab Emirates is another frontrunner with the Enhancing Gene Therapy Project providing investment and partnerships for global biotech companies. Neurological Conditions Common neurological and Middle East and Asia Pacific Cell and Gene Therapy motor neuron diseases like Parkinson's, Alzheimer's, and spinal muscular atrophy are attracting substantial research attention. Outlook With their huge patient populations, rising healthcare spending, and progressive policy support, the Middle East and Asia Pacific offer immense business potential for the growing cell and gene therapy sector over the next decade.

Cell And Gene Therapy Market 2022-2031 | Business Insights, Trends Analysis, And Forecast

Biswadeep 2022-02-14

With updated market numbers according to the effects of the coronavirus, the report provides the most accurate expected cell and gene therapy market growth numbers from 2022-2031. id=3472&type=smp The global cell and gene therapy market is expected to grow from $6. The gene and cell therapy market is expected to reach $21. com/report/cell-and-gene-therapy-global-market-report The Cell And Gene Therapy Global Market Report 2022-31 by The Business Research Company evaluates gene and cell therapy market size, growth rate, drivers, gene and cell therapy industry trends, and major companies. Key Mergers And Acquisitions In The Cell and Gene Therapy Market30.

Cell and Gene Therapy Market to Reach $25.00 Billion by 2027, Reports BIS Research

bisresearch reports 2022-03-01

The premium market intelligence report published by BIS Research titled Global Cell and Gene Therapy Market highlights that the market is projected to reach $25. How can market intelligence on the cell and gene therapy market add value to an organization's decision-making process? How will the urgency of the pandemic influence the global cell and gene therapy market? What is the reimbursement scenario of the products offered in the global cell and gene therapy market? How is each segment of the global cell and gene therapy market expected to grow during the forecast period?

Cell And Gene Therapy Market : By Current Trends, Industry Analysis, Drivers And Forecast 2022 To 2031

Pooja tbrc 2022-11-10

By Product: Cell Therapy, Gene Therapy 2. By Application: Oncology, Neurological Disorders Table Of Contents 1. Global Cell And Gene Therapy Market Competitive Landscape 21. Key Mergers And Acquisitions In The Cell And Gene Therapy Market 22. Appendix Read Related Reports - https://www.

WHO TO FOLLOW